Boule Diagnostics AB (publ)

OM:BOUL Stok Raporu

Piyasa değeri: SEK 273.4m

Boule Diagnostics Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Boule Diagnostics is forecast to grow earnings and revenue by 103.4% and 5.6% per annum respectively. EPS is expected to grow by 103.3% per annum. Return on equity is forecast to be 15.5% in 3 years.

Anahtar bilgiler

103.4%

Kazanç büyüme oranı

103.3%

EPS büyüme oranı

Medical Equipment kazanç büyümesi32.8%
Gelir büyüme oranı5.6%
Gelecekteki özkaynak getirisi15.5%
Analist kapsamı

Low

Son güncelleme27 Oct 2024

Gelecekteki son büyüme güncellemeleri

Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jul 25
Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

May 10
Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Recent updates

Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?

Oct 10
Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?

Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jul 25
Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal

Jul 24
Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal

Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Jun 06
Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)

Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

May 10
Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Mar 20
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results

Feb 09
Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results

Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch

Dec 30
Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch

Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Jul 25
Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate

May 26
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate

Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals

Jul 26
Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals

Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)

Jul 19
Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)

We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt

Mar 06
We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt

Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

Feb 03
Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital

The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing

Apr 29
The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing

Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?

Apr 09
Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Mar 25
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate

Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend

Mar 07
Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend

Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?

Feb 17
Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?

These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively

Jan 30
These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively

Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?

Jan 14
Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?

How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?

Dec 28
How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?

Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

Dec 10
Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate

What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?

Nov 22
What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?

Kazanç ve Gelir Büyüme Tahminleri

OM:BOUL - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SEK Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20266425124622
12/31/20255914422592
12/31/2024559-21215552
9/30/2024563-213-2461N/A
6/30/202457321-783N/A
3/31/202457627-1573N/A
12/31/202357125-3151N/A
9/30/202357219-4336N/A
6/30/202355817-81-8N/A
3/31/202355916-91-19N/A
12/31/202254813-86-11N/A
9/30/202253927-87-13N/A
6/30/202252532-5614N/A
3/31/202249528-3229N/A
12/31/202146323-1343N/A
9/30/2021416-27357N/A
6/30/2021403-131464N/A
3/31/2021383-552573N/A
12/31/2020400-482975N/A
9/30/2020437-82670N/A
6/30/2020470-82976N/A
3/31/2020499352673N/A
12/31/201949938654N/A
9/30/201947632-1441N/A
6/30/201945621-3716N/A
3/31/201944436-5911N/A
12/31/201842441-4223N/A
9/30/201842548-1340N/A
6/30/201842460N/A51N/A
3/31/201842143N/A46N/A
12/31/201742837N/A58N/A
9/30/201742231N/A45N/A
6/30/201742128N/A38N/A
3/31/201741938N/A32N/A
12/31/201639736N/A20N/A
9/30/201638336N/A20N/A
6/30/201636422N/A28N/A
3/31/201634115N/A29N/A
12/31/201533115N/A22N/A
9/30/201533329N/A22N/A
6/30/201531833N/A8N/A
3/31/201530933N/A21N/A
12/31/201430730N/A31N/A
9/30/201428914N/A16N/A
6/30/2014285-68N/A35N/A
3/31/2014287-64N/A23N/A
12/31/2013277-70N/A16N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: BOUL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.1%).

Kazançlar ve Piyasa: BOUL is forecast to become profitable over the next 3 years, which is considered above average market growth.

Yüksek Büyüme Kazançları: BOUL is expected to become profitable in the next 3 years.

Gelir ve Pazar: BOUL's revenue (5.6% per year) is forecast to grow faster than the Swedish market (0.01% per year).

Yüksek Büyüme Geliri: BOUL's revenue (5.6% per year) is forecast to grow slower than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: BOUL's Return on Equity is forecast to be low in 3 years time (15.5%).


Büyüyen şirketleri keşfedin